- Home
- Publications
- Publication Search
- Publication Details
Title
Potential Prophylactic Treatments for COVID-19
Authors
Keywords
-
Journal
Viruses-Basel
Volume 13, Issue 7, Pages 1292
Publisher
MDPI AG
Online
2021-07-05
DOI
10.3390/v13071292
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Early use of nitazoxanide in mild Covid-19 disease: randomised, placebo-controlled trial
- (2021) Patricia R. M. Rocco et al. EUROPEAN RESPIRATORY JOURNAL
- Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia
- (2021) Nicolas de Prost et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
- (2021) Christopher C Butler et al. LANCET
- Role of ivermectin in the prevention of SARS-CoV-2 infection among healthcare workers in India: A matched case-control study
- (2021) Priyamadhaba Behera et al. PLoS One
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
- (2020) Canrong Wu et al. Acta Pharmaceutica Sinica B
- Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection
- (2020) Mihai G. Netea et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID‐19
- (2020) Virginia D. Schmith et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- COVID ‐19: lambda interferon against viral load and hyperinflammation
- (2020) Evangelos Andreakos et al. EMBO Molecular Medicine
- Famotidine Use is Associated with Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
- (2020) Daniel E. Freedberg et al. GASTROENTEROLOGY
- Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine
- (2020) Zahra Sahraei et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
- (2020) Safiya Richardson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- SARS-CoV-2: a storm is raging
- (2020) Savannah F. Pedersen et al. JOURNAL OF CLINICAL INVESTIGATION
- Deployment of convalescent plasma for the prevention and treatment of COVID-19
- (2020) Evan M. Bloch et al. JOURNAL OF CLINICAL INVESTIGATION
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interferon-α2b Treatment for COVID-19
- (2020) Qiong Zhou et al. Frontiers in Immunology
- Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
- (2020) Qingxian Cai et al. Engineering
- COVID-19 attack rate in HIV-infected patients and in PrEP users
- (2020) Caroline Charre et al. AIDS
- Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses
- (2020) Mike Bray et al. ANTIVIRAL RESEARCH
- The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
- (2020) Leon Caly et al. ANTIVIRAL RESEARCH
- The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance
- (2020) Marco Tuccori et al. DRUG SAFETY
- Association between famotidine use and COVID-19 severity in Hong Kong: a territory-wide study
- (2020) Ka Shing Cheung et al. GASTROENTEROLOGY
- Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
- (2020) Abdo A. Elfiky LIFE SCIENCES
- Nitazoxanide/azithromycin combination for COVID-19: A suggested new protocol for early management
- (2020) Mina T. Kelleni PHARMACOLOGICAL RESEARCH
- Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection
- (2020) Roberto Maggio et al. PHARMACOLOGICAL RESEARCH
- Inhaled nitric oxide therapy in acute bronchiolitis: A multicenter randomized clinical trial
- (2020) Aviv Goldbart et al. Scientific Reports
- Role of Lopinavir/Ritonavir in the Treatment of Covid-19: A Review of Current Evidence, Guideline Recommendations, and Perspectives
- (2020) Simone Meini et al. Journal of Clinical Medicine
- A prospective, randomized, open-label trial of early versus late favipiravir in hospitalized patients with COVID-19
- (2020) Yohei Doi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dose Prediction for Repurposing Nitazoxanide in SARS‐CoV‐2 Treatment or Chemoprophylaxis
- (2020) Rajith K.R. Rajoli et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Use of Ivermectin is Associated with Lower Mortality in Hospitalized Patients with COVID-19 (ICON study)
- (2020) Juliana Cepelowicz Rajter et al. CHEST
- Bromhexine Hydrochloride Tablets for the Treatment of Moderate COVID‐19: An Open‐Label Randomized Controlled Pilot Study
- (2020) Ting Li et al. CTS-Clinical and Translational Science
- Re-recognizing bromhexine hydrochloride: pharmaceutical properties and its possible role in treating pediatric COVID-19
- (2020) Qibo Fu et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19
- (2020) Bruno M. Tomazini et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures
- (2020) Kenneth H. Dinnon et al. NATURE
- Favipiravir at high doses has potent antiviral activity in SARS-CoV-2−infected hamsters, whereas hydroxychloroquine lacks activity
- (2020) Suzanne J. F. Kaptein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates
- (2020) Durga Prasanna Misra et al. RHEUMATOLOGY INTERNATIONAL
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis
- (2020) Ashleigh Shannon et al. Nature Communications
- Biological, molecular and pharmacological characteristics of chloroquine, hydroxychloroquine, convalescent plasma, and remdesivir for COVID-19 pandemic: A comparative analysis
- (2020) Sultan Ayoub Meo et al. JOURNAL OF KING SAUD UNIVERSITY SCIENCE
- Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial
- (2020) Khalil Ansarin et al. BioImpacts
- Proton pump inhibitor or famotidine use and severe COVID-19 disease: a propensity score-matched territory-wide study
- (2020) Jiandong Zhou et al. GUT
- A COVID-19 prophylaxis? Lower incidence associated with prophylactic administration of ivermectin
- (2020) Martin D. Hellwig et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors
- (2020) Rachel P. M. Abrams et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial
- (2020) Zarir F. Udwadia et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Lopinavir/ritonavir: Repurposing an old drug for HIV infection in COVID-19 treatment
- (2020) Paola Magro et al. Biomedical Journal
- Lethal mutagenesis of Rift Valley fever virus induced by favipiravir
- (2019) Belén Borrego et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Influenza virus polymerase inhibitors in clinical development
- (2019) Frederick G. Hayden et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Inhibitors of nuclear transport
- (2019) David A Jans et al. CURRENT OPINION IN CELL BIOLOGY
- Favipiravir as a potential countermeasure against neglected and emerging RNA viruses
- (2018) Leen Delang et al. ANTIVIRAL RESEARCH
- Colchicine Pharmacokinetics and Mechanism of Action
- (2018) Christos Angelidis et al. CURRENT PHARMACEUTICAL DESIGN
- Doxycycline as an anti-inflammatory agent: updates in dermatology
- (2017) M. Henehan et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Neurovirulent Murine Coronavirus JHM.SD Uses Cellular Zinc Metalloproteases for Virus Entry and Cell-Cell Fusion
- (2017) Judith M. Phillips et al. JOURNAL OF VIROLOGY
- The end of a dogma: the safety of doxycycline use in young children for malaria treatment
- (2017) Tiphaine Gaillard et al. MALARIA JOURNAL
- Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
- (2017) Yousuke FURUTA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Use of colchicine in pregnancy: a systematic review and meta-analysis
- (2017) Praveen L Indraratna et al. RHEUMATOLOGY
- The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
- (2016) Carina Götestam Skorpen et al. ANNALS OF THE RHEUMATIC DISEASES
- Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay
- (2016) Mizuki Yamamoto et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses
- (2016) Finny S. Varghese et al. ANTIVIRAL RESEARCH
- Thiazolides Elicit Anti-Viral Innate Immunity and Reduce HIV Replication
- (2016) Daria Trabattoni et al. Scientific Reports
- Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus
- (2016) Jean-François Rossignol Journal of Infection and Public Health
- Colchicine Use During Breastfeeding
- (2015) Tina Herscovici et al. Breastfeeding Medicine
- Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis
- (2015) Kentaro Yamada et al. JOURNAL OF INFECTIOUS DISEASES
- Post-exposure prophylaxis against Ebola virus disease with experimental antiviral agents: a case-series of health-care workers
- (2015) Michael Jacobs et al. LANCET INFECTIOUS DISEASES
- Nitazoxanide: A first-in-class broad-spectrum antiviral agent
- (2014) Jean-François Rossignol ANTIVIRAL RESEARCH
- The BCG replacement vaccine VPM1002: from drawing board to clinical trial
- (2014) Stefan HE Kaufmann et al. Expert Review of Vaccines
- Favipiravir (T-705), a novel viral RNA polymerase inhibitor
- (2013) Yousuke Furuta et al. ANTIVIRAL RESEARCH
- Inhibitory effect of doxycycline against dengue virus replication in vitro
- (2013) Hussin A. Rothan et al. ARCHIVES OF VIROLOGY
- Low-dose Interferon-α Treatment Improves Survival and Inflammatory Responses in a Mouse Model of Fulminant Acute Respiratory Distress Syndrome
- (2013) Daisuke Kudo et al. INFLAMMATION
- Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome
- (2013) Takuma Misawa et al. NATURE IMMUNOLOGY
- The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study
- (2013) Geoff Bellingan et al. Lancet Respiratory Medicine
- Nitazoxanide suppresses IL-6 production in LPS-stimulated mouse macrophages and TG-injected mice
- (2012) Seong Keun Hong et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Clinical Perspectives with Long-Term Pulsed Inhaled Nitric Oxide for the Treatment of Pulmonary Arterial Hypertension
- (2012) Robyn J. Barst et al. Pulmonary Circulation
- Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response
- (2011) I. Glowacka et al. JOURNAL OF VIROLOGY
- Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature
- (2010) Michael O. Griffin et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse model
- (2010) Yohichi Kumaki et al. ANTIVIRAL RESEARCH
- Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2
- (2010) S. Matsuyama et al. JOURNAL OF VIROLOGY
- A randomized controlled trial of low-dose recombinant human interferons α-2b nasal spray to prevent acute viral respiratory infections in military recruits
- (2010) LuLu Gao et al. VACCINE
- The Anti-Hepatitis C Agent Nitazoxanide Induces Phosphorylation of Eukaryotic Initiation Factor 2α Via Protein Kinase Activated by Double-Stranded RNA Activation
- (2009) Menashe Elazar et al. GASTROENTEROLOGY
- Inhibitory effects of ivermectin on nitric oxide and prostaglandin E2 production in LPS-stimulated RAW 264.7 macrophages
- (2009) Xuemei Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Chemical biology of tetracycline antibioticsThis paper is one of a selection of papers published in this Special Issue, entitled CSBMCB — Systems and Chemical Biology, and has undergone the Journal's usual peer review process.
- (2008) Bijan Zakeri et al. Biochemistry and Cell Biology
- Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice
- (2008) X. Zhang et al. INFLAMMATION RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search